Bioasis Provides Corporate Update and Announces Suspension of Operations
NEW HAVEN, Conn., June 20, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF, TSX.V:BTI)) (the "Company" or "Bioasis"), a multi-asset rare and orphan disease biopharmaceutical company developing clinical
Bioasis Technologies Inc. (OTCMKTS:BIOAF) Sees Significant Increase in Short Interest
Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) was the recipient of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 19,80
Bioasis Provides Update on Business Operations
NEW HAVEN, Conn., March 23, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF, TSX.V:BTI)) (the "Company" or "Bioasis"), a multi-asset rare and orphan disease biopharmaceutical company developing clinical
Short Interest in Bioasis Technologies Inc. (OTCMKTS:BIOAF) Increases By 28.7%
Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) was the target of a large growth in short interest in January. As of January 31st, there was short interest totalling 32,300 shares, a growth o
Bioasis Announces AGM Results and Provides Update on Financial Position
NEW HAVEN, Conn., Feb. 03, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF, TSX.V:BTI)) (the "Company" or "Bioasis"), a multi-asset rare and orphan disease biopharmaceutical company developing clinical
On Jan 23, 2023, Midatech Pharma PLC Received Termination Notice From Bioasis Technologies Inc. To Terminate Arrangement; On January 26 Co Terminated Securities Purchase Agreement By And Between Company And A Certain Institutional Investor
On Jan 23, 2023, Midatech Pharma PLC Received Termination Notice From Bioasis Technologies Inc. To Terminate Arrangement; On January 26 Co Terminated Securities Purchase Agreement By And Between Compa
Bioasis Technologies Inc. Announces Termination Of Arrangement Agreement With Midatech Pharma Plc
NEW HAVEN, Conn., Jan. 23, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the "Company" or "Bioasis"), a multi-asset rare and orphan disease biopharmaceutical company d
Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending November 30, 2022
NEW HAVEN, Conn., Jan. 19, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the "Company" or "Bioasis"), a multi-asset rare and orphan disease biopharmaceutical company d
Bioasis Technologies Inc. (OTCMKTS:BIOAF) Sees Large Increase in Short Interest
Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) saw a large increase in short interest during the month of December. As of December 30th, there was short interest totalling 73,600 shares, an
Bioasis Technologies Inc. (OTCMKTS:BIOAF) Short Interest Up 429.5% in January
Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) was the target of a significant increase in short interest in January. As of January 15th, there was short interest totalling 73,600 shares, an
Bioasis Technologies Inc. Mails Management Information Circular for Annual and Special Meeting of Securityholders
Bioasis Technologies Inc. Announces Amendments to Arrangement Agreement With Midatech Pharma Plc
Bioasis Technologies Inc. Announces Shareholder Webinar
NEW HAVEN, Conn., Dec. 14, 2022 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (TSXV:BTI) (OTCQB:BIOAF), (the "Company" or "Bioasis"), a multi-asset rare and orphan disease biopharmaceutical company
Bioasis Technologies Inc. Announces Merger With Midatech Pharma Plc
Midatech Pharma PLC Proposed Acquisition of Bioasis Technologies Inc
Midatech Pharma PLC Proposed Acquisition of Bioasis Technologies Inc
Bioasis Technologies Inc. (OTCMKTS:BIOAF) Short Interest Up 32.4% in August
Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) was the target of a large growth in short interest in the month of August. As of August 31st, there was short interest totalling 56,400 shares,
Bioasis Technologies Inc. (OTCMKTS:BIOAF) Short Interest Update
Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) was the target of a significant growth in short interest during the month of August. As of August 15th, there was short interest totalling 42,60
Bioasis Technologies Inc. (OTCMKTS:BIOAF) Short Interest Down 23.3% in July
Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) was the recipient of a significant decrease in short interest in the month of July. As of July 31st, there was short interest totalling 34,600 s
Bioasis Technologies Inc. (OTCMKTS:BIOAF) Sees Significant Decline in Short Interest
Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) saw a significant decrease in short interest during the month of July. As of July 31st, there was short interest totalling 34,600 shares, a dec
Bioasis Technologies Inc. Announces Stock Option Grants
NEW HAVEN, Conn., Aug. 08, 2022 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the "Company" or "Bioasis"), a multi-asset rare and orphan disease biopharmaceutical company d
No Data